Xtrackers Nifty 500 India ETF（IND）ETF 價格、持股與基金資料

US$23.1034

+US$0.1084 · +0.47%

2026年8月24日 09:30 – 2026年8月24日 12:04美國東部時間ET

區間最低: US$22.8801
區間最高: US$23.37

盤中時間採用ET。市場資料可能有所延遲。

關於此 ETF

This fund is designed to deliver investment returns that closely reflect the performance of the Nifty 500 Index. Its primary objective is to track the movements of this benchmark, measured before any of the fund's own management fees or operational expenses are subtracted.

資產類別: Equity
發行機構: Xtrackers
註冊地: US
成立日期: 2025年11月25日
持股數量: 498
ISIN: US23306X7874

主要基金統計

基金資產

460.62萬 USD

費用率

0.19%

NAV

US$23.03

平均成交量

942

成交量

2168.05

當日區間

US$22.8801 – US$23.25

52 週區間

US$20.515 – US$27.40

前收盤價

US$22.995

價格變動

表現

1 天

+0.47%

1 個月

+4.26%

3 個月

+3.79%

今年以來

-7.29%

1 年

-8.32%

3 年

-8.32%

5 年

+5675.85%

價格變動不包括配息、費用、稅費及投資人特定的現金流。

投資組合

主要持股

排名持股代碼權重

01

HDFC BANK LTDHDFCBANK.BOHDFCBANK.BO5.38%

02

ICICI Bank LtdICICIBANK.BOICICIBANK.BO4.95%

03

RELIANCE INDUSTRIESRELIANCE.BORELIANCE.BO4.29%

04

Bharti Airtel LtdBHARTIARTL.BOBHARTIARTL.BO2.86%

05Cash & Cash Equivalents——2.49%

06

Larsen & Toubro LtdLT.BOLT.BO2.33%

07

State Bank Of IndiaSBIN.BOSBIN.BO2.12%

08

Infosys LtdINFY.BOINFY.BO1.90%

09

Axis Bank LtdAXISBANK.BOAXISBANK.BO1.74%

10Y54Mahindra & Mahindra LtdY54164150Y541641501.48%

11

KOTAK MAHINDRA BANK LTD INR 1.0KOTAKBANK.BOKOTAKBANK.BO1.44%

12

BAJAJ FINANCE LTD NPVBAJFINANCE.BOBAJFINANCE.BO1.42%

13

ITC LtdITC.BOITC.BO1.26%

14

Zomato LtdETERNAL.BOETERNAL.BO1.14%

15

TATA CONSULTANCY SVCS LTDTCS.BOTCS.BO1.14%

持股資料更新於 2026年8月24日。

投資組合構成

曝險

國家曝險

前 3 項

India96.16%

Other3.20%

United States0.65%

基金收益

配息

除息日登記日支付日金額

2026年6月18日

Irregular

2026年6月18日

2026年6月26日

US$0.078

Irregular

IND 新聞

gurufocus.com2026年8月16日

AARD SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Aardvark (AARD) Investors of Securities Class Action Lawsuit Deadline on October 13, 2026

[url="]Faruqi and Faruqi, LLP[/url], a leading national securities law firm, is investigating potential claims against Aardvark Therapeutics, Inc. (âAardvarkâ

閱讀原始碼

gurufocus.com2026年8月6日

Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results

Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines

閱讀原始碼

gurufocus.com2026年7月13日

Niagen Bioscience Receives Exclusive U.S. FDA Rare Pediatric Disease (RPD) Designation and European Medicines Agency Orphan Medicinal Product Designation (OMPD) for NB4168 for the Treatment of Ataxia

[url="]Niagen Bioscience, Inc.[/url] (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy ag

閱讀原始碼

gurufocus.com2026年7月9日

JetBlue Launches Largest-Ever Fort Lauderdale Schedule, Reinforcing Long-Term Commitment to South Florida

JetBlue (NASDAQ: JBLU) today continued its significant expansion at Fort Lauderdale-Hollywood International Airport (FLL), with the launch of eight nonstop des

閱讀原始碼

gurufocus.com2026年6月9日

Pentixapharm Announces FDA Clearance of IND for Phase 3 PANDA Study of First-in-Class Cardiovascular Diagnostic Program

Pentixapharm Announces FDA Clearance of IND for Phase 3 PANDA Study of First-in-Class Cardiovascular Diagnostic Program PR News

閱讀原始碼

gurufocus.com2026年6月2日

Imagion Biosystems' IND Application for MagSense® Phase 2 Clinical Trial Clears FDA Review

[url="]Imagion Biosystems, Ltd. (ASX: IBX)[/url] has announced that the US Food and Drug Administration (FDA) completed its review of the company's investigati

閱讀原始碼

更多基金

探索更多 ETF

瀏覽全部 ETF

Vanguard Total International Stock ETF

VXUS

US$87.085

-0.71%

Invesco QQQ Trust, Series 1

QQQ

US$706.84

-0.93%

BNY Mellon Municipal Opportunities ETF

BMOP

US$24.67

-0.06%

Vanguard Total Bond Market ETF

BND

US$72.3735

+0.20%

SPAC and New Issue ETF

SPCK

US$22.08

-0.50%

Vanguard Total International Bond ETF

BNDX

US$47.68

+0.06%

正在載入 ETF 研究

Xtrackers Nifty 500 India ETF

關於此 ETF

主要基金統計

表現

主要持股

曝險

國家曝險

配息

IND 新聞

AARD SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Aardvark (AARD) Investors of Securities Class Action Lawsuit Deadline on October 13, 2026

Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results

Niagen Bioscience Receives Exclusive U.S. FDA Rare Pediatric Disease (RPD) Designation and European Medicines Agency Orphan Medicinal Product Designation (OMPD) for NB4168 for the Treatment of Ataxia

JetBlue Launches Largest-Ever Fort Lauderdale Schedule, Reinforcing Long-Term Commitment to South Florida

Pentixapharm Announces FDA Clearance of IND for Phase 3 PANDA Study of First-in-Class Cardiovascular Diagnostic Program

Imagion Biosystems' IND Application for MagSense® Phase 2 Clinical Trial Clears FDA Review

探索更多 ETF

繼續研究 IND

正在載入 ETF 研究

Xtrackers Nifty 500 India ETF

IND ETF 概覽

關於此 ETF

主要基金統計

表現

主要持股

曝險

國家曝險

配息

IND 新聞

AARD SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Aardvark (AARD) Investors of Securities Class Action Lawsuit Deadline on October 13, 2026

Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results

Niagen Bioscience Receives Exclusive U.S. FDA Rare Pediatric Disease (RPD) Designation and European Medicines Agency Orphan Medicinal Product Designation (OMPD) for NB4168 for the Treatment of Ataxia

JetBlue Launches Largest-Ever Fort Lauderdale Schedule, Reinforcing Long-Term Commitment to South Florida

Pentixapharm Announces FDA Clearance of IND for Phase 3 PANDA Study of First-in-Class Cardiovascular Diagnostic Program

Imagion Biosystems' IND Application for MagSense® Phase 2 Clinical Trial Clears FDA Review

探索更多 ETF

繼續研究 IND